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Objective: To develop a prognostic model for the thirty-day mortality risk 
after adult heart transplantation.  
Methods: In this report we developed a prediction model for the 30-day 
mortality risk after adult heart transplantation. Logistic regression analysis 
was used to develop the model in 1,262 adult patients undergoing primary 
heart transplantation. We evaluated the accuracy of the prediction model; 
the agreement between the predicted probability and the observed mortal-
ity (calibration); and the ability of the model to correctly discriminate be-
tween the discordant survival pairs (discrimination). The internal validity of 
the prediction model was evaluated using the bootstrapping procedures.
Results: Recipients’ age and sex, pre-transplant diagnosis, transplant status, 
waiting time, cardiopulmonary bypass time, donors’ age and sex, donor-
recipient mismatch for BMI and blood type were independent predictors for 
30-day mortality risk after adult heart transplantation. The model showed 
a good calibration and reasonable discrimination (the corrected area under 
the receiver operating characteristic curve was 0.71). The internal validity 
of the prediction model was acceptable. For practical use, we converted 
the prediction model to score chart. 
Conclusion: The accuracy and the validity of the prediction model were 
acceptable. This easy-to-use instrument for predicting the 30-day mortal-
ity risk after adult heart transplantation would benefit decision-making by 
classifying recipients according to their mortality risk and allowing optimal 
allocation of a donor to a recipient for heart transplantation.
(J Kardiol Indones. 2015;36:4-13)
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Penelitian Klinis
Tujuan: Membuat model prognostik mortalitas 30-hari setelah transplantasi jantung.  
Metode: Kami melaporkan pembuatan model prognostik mortalitas 30-hari setelah transplantasi jantung pada pasien dewasa. 
Analisis regresi logistik digunakan untuk membuat model menggunakan data 1,262 pasien dewasa yang menjalani transplan-
tasi jantung. Akurasi model dinilai dari aspek kalibrasi (kesesuaian antara probabilitas yang diprediksi dengan mortalitas yang 
diobservasi) serta diskriminasi (kemapuan model untuk membedakan pasien dengan probabilitas kematian yang tinggi dan 
rendah dalam waktu 30 hari setelah transplantasi). Validitas internal dinilai menggunakan teknik bootstrapping. 
Results: Usia dan jenis kelamin resipien, diagnosis pre-transplantasi, status transplantasi, waktu tunggu, durasi operasi bypass 
kardiopulmoner, usia dan jenis kelamin donor, serta ketidaksesuaian indeks masa tubuh dan golongan darah donor-resipien 
terpilih sebagai prediktor independen mortalitas 30-hari setelah transplantasi jantung. Model menunjukkan kalibrasi dan 
diskriminasi yang cukup baik (area di bawah the receiver operating characteristic curve adalah 0.71). Validitas internal model 
memadai. Untuk penggunaan dalam praktik sehari-hari, kami mentransformasi model logistik menjadi score chart. 
Conclusion: Model prognostik mortalitas 30-hari setelah transplantasi jantung pada pasien dewasa ini memiliki akurasi dan 
validitas yang memadai. Model ini dapat membantu pengambilan keputusan melalui stratifikasi resipien berdasarkan probabilitas 
kematian setelah transplantasi dan memungkinkan alokasi donor transplantasi jantung secara lebih optimal. 
(J Kardiol Indones. 2015;36:4-13)
Keywords: transplantasi jantung, mortalitas, risiko, scoring system, model prediksi
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Introduction
Heart transplantation is the treatment of choice for 
patients with end-stage heart failure, in particular 
when it is severely impacting daily life (New York 
Heart Association class III or IV) despite maximal 
medical therapy, notably for those with left ventricular 
ejection fraction of 25% or less.1-5 Several studies on 
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risk factors of mortality in heart transplantation have 
been published.2,6 Recently, we have shown the survival 
risk to be stable over 3 subsequent 5-year periods of 
heart transplantation.7 Yet, a comprehensive prediction 
model for post-transplant survival is lacking. 
There are few previous studies which attempted 
to predict mortality risk,8,9 but to our knowledge no 
comprehensive prediction model has been published 
yet. Some preoperative risk stratification models 
for heart transplantation have been developed,9,10 
but their predictive accuracy, i.e., calibration and 
discrimination have not been reported. This limits 
their generalizability and clinical applicability. 
Anyanwu and colleagues8 attempted to derive a simple 
model for risk stratification after heart transplantation, 
but unfortunately their study population was too small 
to allow adequate statistical modelling. 
Using a comprehensive database from a previous 
study including recipient, donor, pre- and peri-
operative characteristics,11 we developed a model for 
predicting the 30-day mortality risk after adult heart 
transplantation. The 30-day mortality was chosen as 
outcome for the model because it is a principal bench 
mark for successful surgical procedures. While the 
model should allow accurate identification of patients 
at high and low 30-day mortality risk it should be easily 
applicable. Besides providing important information to 
patients and their families, such model could support 
cardiac transplant team and surgeons to classify 
patients according to their mortality risk, and hence 
support decision on optimal allocation of the donor 
hearts to patients waiting for heart transplantation. 
Methods
Study population
The study population consisted of 1,262 adult patients 
undergoing primary heart transplantation between 
March 1989 and December 2004 at the Heart & 
Diabetes Center North Rhine Westphalia in Bad 
Oeynhausen, Germany. Donor and recipient were 




Our institutional review board at the Heart & Dia-
betes Center North Rhine Westphalia in Bad Oey-
nhausen, Germany approved this clinical follow-up 
study. According to general institutional and national 
regulations of good epidemiological research practice 
a waiver for informed consent was given. This was 
because anonimised data were used.
Surgical techniques and immunosuppressive 
therapy
Donor heart procurement and preservation was achieved 
by combination of cold cardioplegic arrest, mainly 
using histidine–buffered tryptophane–ketoglutarate 
cardioplegia solution (Bretschneider-Custodiol; 
Kohler Chemie, Alsbach-Hahnlein, Germany) and 
topical hypothermia. All heart transplantations were 
performed orthotopically.12 
Initial immunosuppressive regimen included 
cyclosporine A, azathioprine, and steroid. After 
early postoperative phase, double-drug therapy with 
cyclosporine A and azathioprine was preferred. In case 
of clinical- or biopsy-proven rejection, steroid-pulse 
therapy was initiated. Oral steroid maintenance was 
given only in case of recurrent rejection. 
Follow-up and data collection
All survivors were regularly followed-up through 
our out-patient’s service unit or by telephone 
interview with the patients, their relatives or family/
referring physician. All data of recipients and donors 
were collected prospectively and maintained on 
a computerized database. Follow-up was 100% 
complete. The main outcome was the 30-day mortality 
after heart transplantation, which was defined as death 
within 30 days after heart transplantation.
Predictors
Using reported findings on risk factors for early 
mortality after heart transplantation,13 we selected 
the predictors for inclusion in the model. We 
selected 4 clusters of predictors relating to recipient 
characteristics, notably age, sex, body mass index 
(BMI), blood type, pretransplant diagnosis, previous 
sternotomy, transplant status, waiting time, and need 
of ventricular assist device; donor characteristics, 
notably age, sex, BMI, blood type, cause of death, need 
of cardiopulmonary resuscitation, and catecholamine; 
donor-recipient mismatch, notably sex, BMI, and 
blood type; and operative data, notably ischemic time 
and cardiopulmonary bypass time. All these variables 
were routinely recorded in our clinical database.
Tjang YS et al: Prognostic model for mortality risk after heart transplantation




First, we tested the univariable association of each 
predictor with 30-day mortality by using chi-square 
test for categorical variables, and the unpaired 2-tailed 
t-test or Mann-Whitney U test for continuous variables. 
Predictors with a p-value equal to or below 0.25 were 
selected for inclusion in the subsequent multivariable 
analysis. In building the final multivariable model 
we used a hierarchical approach that follows routine 
practice as close as possible. Our intention was to 
retain the most easily obtainable clinical predictors 
with the highest predictive value. For this, we applied 
a backward stepwise selection procedure and excluded 
predictors a p-value exceeded 0.25. We did not include 
interaction terms in any step of building the prediction 
model.13  We used SPSS software, version 14.0 (SPSS 
Inc., Chicago, Illinois).
The predictive accuracy
The predictive accuracy of the final model was 
quantified by using calibration and discrimination 
measures. Calibration, i.e., the agreement between 
the predicted probability and the observed death, was 
assessed graphically (generated in S-Plus Hmisc library 
“val.prob” function) and tested with the Hosmer–
Lemeshow test, for which a p-value larger than or equal 
to 0.10 reflects good calibration.14 The model’s ability 
to discriminate between discordant survival pairs, 
i.e., one dies and one survives (discrimination) was 
determined with the area under the receiver operating 
characteristic curve area (AUC). AUC illustrates the 
relation between the false positive rate (1-specificity) 
and the true-positive rate (sensitivity) of death. It can 
range from 0.5 (no discrimination) to 1.0 (perfect 
discrimination).15 
Validation
A bootstrapping technique was used to assess the 
internal validity of the model.13,14 Bootstrap samples 
were drawn from the full data set with replacement 
and 100 replications. The backward selection of 
variables and model fitting was repeated within each 
bootstrap sample. This bootstrapping technique 
produced a corrected model’s AUC and a correction 
factor (ranges from 0 to 1). The regression coefficients 
of the predictors in the model were multiplied by this 
correction factor to prevent optimism (i.e. too low 
or too high estimates) in similar future patients.14,16 
For these analyses we used S-plus 6.2 Professional 
(Insightful Corp., Seattle, WA, USA).
Score chart
To facilitate the application of the prediction model 
in practice, the final regression model was converted 
to a score chart. First, the model was first transformed 
into a nomogram (S-Plus Hmisc and Design library, 
function nomogram). A nomogram has a reference 
line for reading the score for each predictor in the 
model (default range 0-100). Based on this nomogram, 
we created a simple to use score chart. Once the 
reader manually totals the scores, the corresponding 
predicted probabilities of 30-day mortality risk of every 
individual can be eyeballed at bottom. 
Results
Of 1,262 patients, 107 died within 30 days after 
heart transplantation (30-day mortality risk: 9%, 
95%CI: 7% - 11%). The baseline characteristics and 
their univariable association with the outcome were 
presented in Table 1. We started the multivariable 
modelling with 14 variables with a univariable p-value 
≤0.25. 
Previous sternotomy, donor cause of death, 
donor-recipient mismatch for sex, and ischemic 
time subsequently showed a p-value > 0.25 for their 
multivariable association with the outcome, and thus 
were not included in the final model. Recipient age and 
sex, pretransplant diagnosis, transplant status, waiting 
time, donor age and sex, donor-recipient mismatch 
for BMI and blood type, and cardiopulmonary bypass 
time composed the final model (Table 2).
The prediction model’s accuracy and validity 
There was no significant difference between the 
predicted probability and actual death (Hosmer-
Lemeshow test of the final model gave a p-value of 
0.218). This was confirmed by the calibration plot 
of the model (Figure 1). Most of the plotted points 
were lying close to the diagonal line, demonstrating a 
good calibration. The final model had an AUC of 0.74 
(95% CI: 0.69 – 0.79), which meant that given 100 
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Table 1 Baseline characteristics and univariable association with 30-day mortality risk after adult heart transplantation.
Variable Total (n = 1,262) Death (n = 107) Survivor (1,155) P-value
Recipient
Age (years)* 53.9 (11.1) 57 (10.8) 53.6 (11.1) 0.003
Sex, female 197 (16) 24 (22) 173 (15) 0.04
Body mass index (kg/m2)* 23.5 (3) 23.2 (3) 23.5 (3) 0.33
Blood type
   A 558 (44) 51 (48) 507 (44) 0.45
   B 138 (11) 8 (8) 30 (11)
   O 478 (38) 43 (40) 435 (38)
   AB 88 (7) 5 (5) 83 (7)
Pretransplant diagnosis
   Dilated cardiomyopathy 631 (50) 40 (37) 591 (51) 0.01
   Ischemic cardiomyopathy 543 (43) 55 (51) 488 (42)
   Other 88 (7) 12 (11) 76 (7)
Previous sternotomy 411 (33) 44 (41) 367 (32) 0.05
Low-urgency status 1141 (90) 101 (94) 1041 (90) 0.15
Waiting time (months)† 3.3 (0.9 – 10.8) 6.4 (1.8 – 13.9) 3.1 (0.9 – 10.4)) 0.002
Ventricular assist device 223 (18) 22 (21) 201 (17) 0.41
Donor
Age (years)* 36.5 (13.6) 41.2 (12.6) 36.1 (13.6) < 0.001
Sex, female 627 (50) 72 (67) 555 (48) < 0.001
Body mass index (kg/m2)* 23.9 (3.4) 24.1 (4.2) 23.9 (3.4) 0.45
Blood type
   A 539 (43) 47 (44) 492 (43) 0.41
   B 137 (11) 10 (9) 127 (11)
   O 523 (42) 48 (45) 475 (41)
   AB 63 (5) 2 (2) 61 (5)
Cause of death
   Trauma 478 (38) 28 (26) 450 (39) 0.002
   Cerebrovascular accident 561 (44) 65 (61) 496 (43)
   Other 223 (18) 14 (13) 209 (18)
Cardiopulmonary resuscitation 192 (15) 16 (15) 176 (15) 0.94
Catecholamine 772 (61) 64 (60) 708 (61) 0.76
Donor-recipient mismatch
Sex
   Male donor to female recipient 55 (4) 5 (5) 50 (4) 0.04
   Female donor to male recipient 485 (38) 53 (50) 432 (37)
Body mass index ratio
   < 0.8 (undermatch) 79 (6) 8 (8) 71 (6) 0.1
   > 1.2 (overmatch) 178 (14) 22 (21) 156 (14)
Non-identical blood type 74 (6) 9 (8) 65 (6) 0.24
Operative data
Ischemic time (minutes)* 194.5 (40.4) 206.6 (40.2) 193.4 (40.3) 0.001
Cardiopulmonary bypass time (minutes)* 114 (45.6) 139.6 (67) 111.6 (42.4) < 0.001
Data presented as n (%) unless otherwise stated.
* Mean (± standard deviation)
† Median (interquartile range)
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Table 2: Multivariable association of the predictors in the final prediction model for 30-day mortality 
risk after adult heart transplantation.
Variable B SE OR 95% CI
Recipient’s age (years) 0.015 0.012 1.02 0.99 – 1.04
Recipient sex (female) 0.604 0.276 1.83 1.07 -3.14
Pretransplant diagnosis
   Dilated cardiomyopathy 1 Reference
   Ischemic cardiomyopathy 0.287 0.237 1.33 0.84 – 2.12
   Others 0.574 0.370 1.78 0.86 – 3.66
Low-urgency status 0.867 0.484 2.38 0.92 – 6.15
Waiting time (months) 0.026 0.012 1.03 1.01 – 1.05
Donor’s age (years) 0.018 0.009 1.02 1.01 – 1.04
Donor sex (female) 0.591 0.231 1.81 1.15 – 2.84
Donor-recipient body mass index ratio
   0.8 – 1.2 (match) 1 Reference
   < 0.8 (undermatch) 0.189 0.424 1.21 0.53 – 2.77
   > 1.2 (overmatch) 0.473 0.272 1.61 0.94 – 2.74
Donor-recipient blood group (non-identical) 0.678 0.408 1.97 0.89 – 4.38
Cardiopulmonary bypass time 0.010 < 0.001 1.010 1.007 – 1.014
SE: standard error; CI: confidence interval; OR: odds ratio
Table 3: Score chart for 30-day mortality risk after adult heart transplantation
RECIPIENT  DONOR  
Predictors Value Score if present Answer Predictors Value Score if present Answer
Age 0-15 years 0  Age 0-5 years 0  
 > 15 years (age recipient 
-15) / 3
  > 5 years (age donor -5) 
/ 2.5
 
Sex Male 0  Sex Male 0  
 Female 13   Female 13  
Ischemic cardiomyopathy No 0  Blood type Identical 0  
Yes 6   Non-identical 20  
Other than ischemic and di-
lated cardiomyopathy
No 0  Donor-recipient 
body mass index 
ratio
Match 0  
Yes 12  Undermatch 5  
Urgency status High 0  Overmatch 11  
 Low 18   
Waiting time None 0   
 In months waiting time * 0.6      
Cardiopulmonary bypass time 
(CBP)*
In minutes CBP time / 4.5
Recipient total scores  Donor total scores
Total scores (Recipient + Donor)
* Estimated by the skill of the surgeon at the facility
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discordant survival pairs, i.e., one dies and one survives, 
the model could correctly discriminate 74% of them. 
From the bootstrapping procedure, a correction 
factor of 0.81 was obtained; showing an acceptable 
internal validity. The corrected AUC was 0.71. When 
a predicted probability of 12% was chosen as the cut-
off point for stratifying high and low risk of 30-day 
mortality after the transplantation, the sensitivity was 
57% and the specificity was 80% (Figure 2).
The score chart and its application
To enhance clinical usefulness of the model we 
transformed the final regression model into a score 
chart (Table 3). A physician could easily calculate the 
total points given donor’s and recipient’s characteristics 
and afterwards determine the corresponding predicted 
probability of the 30-day mortality after heart 
transplantation, which increased steeply for total points 
of 100 or higher
For example, a 50 year old male patient was diag-
nosed with dilated cardiomyopathy. The transplanta-
tion was not urgent and he had been on the waiting list 
for 10 months. There was a new donor candidate, a 40 
year old female, who had a different blood type from 
the recipient, and a BMI ratio 0.75 over the recipient. 
Unfortunately, there was no skilled surgeon at the facil-
ity and the estimated CBP time would be around 240 
minutes. For this case, the recipient’s characteristics 
scored 89 ((50-15)/3+0+0+0+18+(10*0.6)+(240/4.5)), 
while the donor’s characteristics scored 52 ((40-
5)/2.5+13+20+5), with a total score of 141. The cor-
responding predicted probability of 30-days mortality 
after heart transplantation was about 44%. If only there 
was a skilled surgeon who could shorten CBP time to 
120 minutes, the recipient’s characteristics would score 
62.3 ((50-15)/3+0+0+0+18+(10*0.6)+(120/4.5)), 
while the donor’s characteristics remained 52, with a 
total score of 114.3 and the corresponding predicted 
probability of 30-days mortality of about 20%.
The calibration plot illustrates the observed mortality versus 
the predicted probability of the 30-day mortality after adult 
heart transplantation. The solid line is a smoothed curve that 
represents a non-parametric estimate of the relation between 
the predicted probability and the observed mortality. Ideally, 
this line fits the diagonal dotted line that represents perfect 
calibration. The triangles indicate the observed mortality 
risk per equal-size-deciles of the predicted probability of the 
30-day mortality. Distribution of the predicted probabilities 
is indicated with vertical lines at the bottom.


























Figure 1. Calibration plot showing the observed mortality versus the predicted probability of the 
30-day mortality after adult heart transplantation.  
Figure 1. Calibration plot showing the observed mortality 
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Figure 2. Discriminative ability of the final model for prediction of the 30-day mortality risk after adult heart transplantation. 
Figure 2. Discriminative ability of the final model for 
prediction of the 30-day mortality risk after adult heart 
transplantation.
Discriminative ability of the final prediction model of the 
30-day mortality risk after adult heart transplantation. The 
corrected area under the receiver operator characteristic 
curve was 0.71, which reflects a good discrimination. Given 
5% predicted probability of 30-days mortality, the specifi-
city is 43% and sensitivity is 85% (▲); at 10% predicted 
probability, the specificity is 75% and sensitivity is 62% (
); and at 12% predicted probability, the specificity is 80% 
and sensitivity is 57% (•).
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Discussion
The present analysis based on data from a large cohort 
of heart transplant patients resulted in a novel simple 
model that may be used to adequately predict the 30-
day mortality risk after adult heart transplantation. 
We show that recipients’ age and sex, pretransplant 
diagnosis, transplant status, waiting time, donor age 
and sex, donor-recipient mismatch for BMI and blood 
type, and cardiopulmonary bypass time are independ-
ent predictors for the 30-day mortality risk after adult 
heart transplantation. 
The effect of donor and recipient’s sex on the 
outcome after heart transplantation is a complex issue 
and remains uncertain. Reed and colleagues17 sug-
gested that female recipients had decreased survival 
compared to male recipients. Female recipients have 
been known to have a higher frequency of rejection 
and more likely requires inotropic support before 
surgery. 1,18 Female donors have been also identified 
as risk factor in many studies. 4,19 It has been sug-
gested that heart from male donors improves results 
for recipient with pulmonary hypertension due to 
a greater right ventricular mass in larger male heart 
as compared with female one. The International 
Society for Heart & Lung Transplantation registry5 
consistently confirmed that female recipient or donor 
was a significant risk factor of mortality after heart 
transplantation. Donor-recipient sex mismatch has 
been reported to increase the number of rejection 
episodes and reduce creatinine clearance, survival, 
and censored survival in the first year after heart trans-
plantation.20 However, De Santo and colleagues21 
found that recipient or donor sex as well as donor-
recipient sex mismatch did not significantly modify 
the short and mid-term survival, functional recovery 
and freedom from rejection. They attributed these 
results to a correct donor-recipient size matching. 
One may speculate that female donor heart is simply 
unable to support the circulation of male recipient 
due to its small size or poor ventricular function. In 
our study, we found that either recipient or donor 
sex was an independent predictor of poor outcome, 
but donor-recipient sex mismatch was not. 
We also found that individual BMI of either re-
cipient or donor was not an independent predictor 
for the 30-day mortality after adult heart transplanta-
tion. However, donor-recipient BMI mismatch was 
an independent predictor for decreased survival. A 
donor-recipient BMI mismatch can occur in two 
directions: overmatch and undermatch. An over-
match donor heart should not be transplanted to a 
recipient whose native heart disease does not result in 
cardiomegaly or when there has been previous cardiac 
surgery resulted in rigidity of the mediastinum.22 
Severe overmatch can produce serious restricted 
physiology (and potentially graft failure) if the donor 
heart can not be accommodated by maneuvers such 
as incising the pericardium which allows the donor 
heart to protrude into the left pleural space. This 
results the inability to close the chest without cardiac 
compression. Severe undermatch is important due 
to concerns that the donor heart will be unable to 
support the circulation. Besides, there are potential 
reduced reserves for the load imposed by primary 
graft dysfunction associated with reperfusion injury 
or hemodynamically significant rejection.
Heart transplant status and waiting time to heart 
transplantation remains a crucial issue. We found 
that heart transplantation with a high-urgency status 
and shorter waiting time may improve outcome. We 
believe that heart transplantation should be performed 
as soon as possible before other end-organ failure in the 
recipient develops. Cardiopulmonary bypass time may 
compromise results. Longer cardiopulmonary bypass 
time leads to severe depletion of clotting factors, and 
thereby increases mortality through the postoperative 
complication such as massive bleeding. In a situation 
where a long cardiopulmonary bypass time due to 
previous cardiac surgery with expected scar tissue is 
estimated, the decision on who will perform the heart 
transplantation should be carefully considered.
Our prediction model is easily applicable in 
clinical practice since it comprises predictors which 
are commonly available and easily obtainable pre- or 
perioperatively for most heart transplant patients. 
When this model is used pre-operatively, we can 
estimate CBP time based on history of previous 
surgery or the presence of skilled surgeon in the facility. 
This model could also be used to predict the 30-days 
mortality given complete data of recipient, donor, 
and the operation. In building our model we followed 
routine clinical practice as much as possible. For this, 
we used data obtained from a large heart center with 
a large study population with a complete follow-up of 
adult patients undergoing heart transplantation from 
about 16 subsequent years.
Our prediction model could predict 30-day 
mortality after adult heart transplantation with 
acceptable accuracy. The calibration plot shows that 
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the predicted probability categories are close to the 
ideal line. Hence, in general our model is rather 
well calibrated over the complete range of predicted 
probabilities. After correction for optimism, the AUC 
changed from 0.74 to 0.71, which shows that AUC 
of 0.71 is the figure that we could expect from the 
application of this model in a new population. As always 
there are opportunities to improve prediction models. 
In general, including more (important) predictors into 
the model will improve model’s discrimination. Our 
data was derived from a database which was initially 
not prepared for research purposes. Therefore, one 
of our study limitations is that we unfortunately lost 
information on parameters known to be predictive 
for outcome after heart transplantation (e.g., recipient 
renal function, pulmonary function, vascular disease, 
etc; donor left ventricular hypertrophy, etc.). These 
presumed predictors may likely causally influence 
outcome but their additive predictive value are yet 
unknown. Perhaps, it is possible to include them and 
other data in an updated model or a further prospective 
study. 
What is more important is determining the 
optimal cut-off point of the predicted probability for 
risk stratification because it will influence the amount 
of misclassification. When we considered 5% predicted 
probability of 30-days mortality as the cut-off and 
consequently performing heart transplantation among 
cases with lower probability, the sensitivity is 85%. 
Figure 2 clearly demonstrated that the higher the 
cut-off point, the higher the specificity, at the cost of 
lower sensitivity, and vice versa.
Small number of events relative to the high number 
of potential  predictors is a common limitation in many 
studies. For developing a reliable prediction model, 
the rule of thumb is that per candidate predictor there 
should be at least 10 events (1 to 10 ratio).23 In our 
cohort, we had 14 potential predictors with 107 events 
(1 to 7.6). Nevertheless, the bootstrapping procedures 
showed that the internal validity of the model was 
acceptable.13,14 Still, external validation or perhaps 
even update of our model in a new population, i.e. 
in USA or other countries, should ideally follow to 
apply our prediction model to other populations with 
confidence.   
In conclusion, we have developed and validated a 
prediction model for the 30-day mortality risk after 
adult heart transplantation by using simple predictors 
which are generally available in the clinical setting. 
Our model may serve clinicians in predicting the 
outcome after adult heart transplantation, who will 
then provide this information to patients and their 
family for their consideration. Moreover, the score 
chart may assist the heart transplant team and surgeon 
in risk stratification. Thereby, our prediction model can 
be used for matching donor to recipient and to assist 
decision on optimal allocation of a donor heart to a 
patient waiting for heart transplantation.
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